These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 6420635)

  • 21. The distribution and metabolism of arachidonic acid in rabbit platelets during aggregation and its modification by drugs.
    Blackwell GJ; Duncombe WG; Flower RJ; Parsons MF; Vane JR
    Br J Pharmacol; 1977 Feb; 59(2):353-66. PubMed ID: 837023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PDGF modifies phosphoinositide metabolism and inhibits aggregation and release in human platelets.
    Bryckaert MC; Rendu F; Tobelem G; Caen J
    Biochem Biophys Res Commun; 1986 Feb; 135(1):52-7. PubMed ID: 3006686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered phospholipid metabolism in thrombin-stimulated human platelets.
    Holub BJ
    Can J Biochem Cell Biol; 1984 Jun; 62(6):341-51. PubMed ID: 6380684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective release of archidonic acid from the phospholipids of human platelets in response to thrombin.
    Bills TK; Smith JB; Silver MJ
    J Clin Invest; 1977 Jul; 60(1):1-6. PubMed ID: 874074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulated platelets release equivalent amounts of arachidonate from phosphatidylcholine, phosphatidylethanolamine, and inositides.
    Broekman MJ
    J Lipid Res; 1986 Aug; 27(8):884-91. PubMed ID: 3021886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nicergoline, an anti-aggregating agent which inhibits release of arachidonic acid from human platelet phospholipids.
    Lagarde M; Guichardant M; Ghazi I; Dechavanne M
    Prostaglandins; 1980 Apr; 19(4):551-7. PubMed ID: 7384555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory action of soluble elastin on thromboxane B2 formation in blood platelets.
    Sekiya K; Okuda H
    Biochim Biophys Acta; 1984 Mar; 797(3):348-53. PubMed ID: 6320905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. Effect of albumin on arachidonate metabolism in platelets.
    Rao AK; Koike K; Day HJ; Smith JB; Holmsen H
    Am J Clin Pathol; 1985 Jun; 83(6):687-96. PubMed ID: 3923822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of cholesterol on production of thromboxane b2 by platelets in vitro.
    Stuart MJ; Gerrard JM; White JG
    N Engl J Med; 1980 Jan; 302(1):6-10. PubMed ID: 7350406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonyl-meth oxy coumarin) inhibits the release of arachidonic acid in human platelets stimulated by thrombin.
    Porcellati S; Costantini V; Prosdocimi M; Pistolesi R; Porrovecchio P; Nenci GG; Goracci G
    Thromb Res; 1987 Jul; 47(1):15-24. PubMed ID: 3116710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased phosphatidic acid and decreased lysophosphatidic acid in response to thrombin is associated with inhibition of platelet aggregation.
    Gerrard JM; Robinson P; Narvey M; McNicol A
    Biochem Cell Biol; 1993; 71(9-10):432-9. PubMed ID: 8192895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmin inhibition of platelet function and of arachidonic acid metabolism.
    Schafer AI; Adelman B
    J Clin Invest; 1985 Feb; 75(2):456-61. PubMed ID: 3156149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phospholipase A2 and platelet aggregation.
    Blackwell GJ
    Adv Prostaglandin Thromboxane Res; 1978; 3():137-42. PubMed ID: 655004
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolic properties of human platelet membranes. II. Thrombin-induced phosphorylation of membrane lipids and demonstration of phosphorylating enzymes in the platelet membrane.
    Kaulen HD; Gross R
    Thromb Haemost; 1976 Apr; 35(2):364-76. PubMed ID: 184560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential energy requirements for platelet responses. A simultaneous study of aggregation, three secretory processes, arachidonate liberation, phosphatidylinositol breakdown and phosphatidate production.
    Holmsen H; Kaplan KL; Dangelmaier CA
    Biochem J; 1982 Oct; 208(1):9-18. PubMed ID: 6218802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formation of lysophosphatidylinositol in platelets stimulated with thrombin or ionophore A23187.
    Billah MM; Lapetina EG
    J Biol Chem; 1982 May; 257(9):5196-200. PubMed ID: 6802848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-ethylmaleimide inhibits Ca2+ influx induced by collagen or arachidonate on rabbit platelets.
    Sato T; Hashizume T; Fujii T
    Biochim Biophys Acta; 1987 May; 928(3):266-71. PubMed ID: 3105597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of membrane cholesterol on phospholipid metabolism in thrombin-stimulated platelets. Enhanced activation of platelet phospholipase(s) for liberation of arachidonic acid.
    Kramer RM; Jakubowski JA; Vaillancourt R; Deykin D
    J Biol Chem; 1982 Jun; 257(12):6844-9. PubMed ID: 7085608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mepacrine (quinacrine) inhibition of thrombin-induced platelet responses can be overcome by lysophosphatidic acid.
    McCrea JM; Robinson P; Gerrard JM
    Biochim Biophys Acta; 1985 Oct; 842(2-3):189-94. PubMed ID: 3931692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mobilization of arachidonic acid in platelets exposed to thrombin or ionophore A23187. Effects of adenosine triphosphate deprivation.
    Rittenhouse-Simmons S; Deykin D
    J Clin Invest; 1977 Aug; 60(2):495-8. PubMed ID: 326813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.